Clinical impact of high platelet reactivity in patients with atrial fibrillation and concomitant percutaneous coronary intervention on dual or triple antithrombotic therapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Clinical impact of high platelet reactivity in patients with atrial fibrillation and concomitant percutaneous coronary intervention on dual or triple antithrombotic therapy ; volume:55 ; number:4 ; day:11 ; month:3 ; year:2023 ; pages:667-679 ; date:5.2023
Journal of thrombosis and thrombolysis ; 55, Heft 4 (11.3.2023), 667-679, 5.2023
- Creator
-
Berteotti, M.
Gori, A. M.
Giusti, B.
Fortini, A.
Grossi, G.
Ciardetti, N.
Migliorini, A.
Lotti, E.
Valenti, R.
Mario, C. Di
Marchionni, N.
Marcucci, R.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s11239-023-02784-z
- URN
-
urn:nbn:de:101:1-2023090510372729349255
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Berteotti, M.
- Gori, A. M.
- Giusti, B.
- Fortini, A.
- Grossi, G.
- Ciardetti, N.
- Migliorini, A.
- Lotti, E.
- Valenti, R.
- Mario, C. Di
- Marchionni, N.
- Marcucci, R.
- SpringerLink (Online service)
Other Objects (12)
Antithrombotic treatment in atrial fibrillation patients needing percutaneous coronary intervention
Optimal antithrombotic treatment of patients with atrial fibrillation undergoing percutaneous coronary intervention: triple therapy is too much!
The WOEST 2 registry : A prospective registry on antithrombotic therapy in atrial fibrillation patients undergoing percutaneous coronary intervention
How cardiologists manage antithrombotic treatment of patients with atrial fibrillation undergoing percutaneous coronary stenting: the WOEST survey 2018
Antithrombotic therapy in coronary artery disease patients with atrial fibrillation
Anti-thrombotic strategies in patients with atrial fibrillation undergoing PCI
Characteristics and antithrombotic treatment patterns of patients with concomitant coronary artery disease and atrial fibrillation from Thailand’s COOL-AF registry
Antithrombotic treatment in elderly patients with atrial fibrillation: a practical approach
Antithrombotic therapy in patients with atrial fibrillation and coronary artery disease
Atrial fibrillation: trends in prevalence and antithrombotic prescriptions in the community
Optimal long-term antithrombotic management of atrial fibrillation: life cycle management
Safety and efficacy of dual versus triple antithrombotic therapy in Patients with atrial fibrillation undergoing percutaneous coronary intervention: a meta-analysis
Antithrombotic treatment in atrial fibrillation patients needing percutaneous coronary intervention
Optimal antithrombotic treatment of patients with atrial fibrillation undergoing percutaneous coronary intervention: triple therapy is too much!
The WOEST 2 registry : A prospective registry on antithrombotic therapy in atrial fibrillation patients undergoing percutaneous coronary intervention
How cardiologists manage antithrombotic treatment of patients with atrial fibrillation undergoing percutaneous coronary stenting: the WOEST survey 2018
Antithrombotic therapy in coronary artery disease patients with atrial fibrillation
Anti-thrombotic strategies in patients with atrial fibrillation undergoing PCI
Characteristics and antithrombotic treatment patterns of patients with concomitant coronary artery disease and atrial fibrillation from Thailand’s COOL-AF registry
Antithrombotic treatment in elderly patients with atrial fibrillation: a practical approach
Antithrombotic therapy in patients with atrial fibrillation and coronary artery disease
Atrial fibrillation: trends in prevalence and antithrombotic prescriptions in the community
Optimal long-term antithrombotic management of atrial fibrillation: life cycle management
Safety and efficacy of dual versus triple antithrombotic therapy in Patients with atrial fibrillation undergoing percutaneous coronary intervention: a meta-analysis
Antithrombotic treatment in atrial fibrillation patients needing percutaneous coronary intervention
Optimal antithrombotic treatment of patients with atrial fibrillation undergoing percutaneous coronary intervention: triple therapy is too much!
The WOEST 2 registry : A prospective registry on antithrombotic therapy in atrial fibrillation patients undergoing percutaneous coronary intervention
How cardiologists manage antithrombotic treatment of patients with atrial fibrillation undergoing percutaneous coronary stenting: the WOEST survey 2018
Antithrombotic therapy in coronary artery disease patients with atrial fibrillation
Anti-thrombotic strategies in patients with atrial fibrillation undergoing PCI
Characteristics and antithrombotic treatment patterns of patients with concomitant coronary artery disease and atrial fibrillation from Thailand’s COOL-AF registry
Antithrombotic treatment in elderly patients with atrial fibrillation: a practical approach
Antithrombotic therapy in patients with atrial fibrillation and coronary artery disease
Atrial fibrillation: trends in prevalence and antithrombotic prescriptions in the community
Optimal long-term antithrombotic management of atrial fibrillation: life cycle management